WHOLE SHINE MEDICAL(002622)

Search documents
皓宸医疗(002622) - 2015 Q4 - 年度财报
2016-03-30 16:00
吉林永大集团股份有限公司 2015 年度报告 吉林永大集团股份有限公司 Jilin Yongda Group CO., LTD. 2015 年度报告 股票简称:永大集团 股票代码:002622 二〇一六年三月 1 吉林永大集团股份有限公司 2015 年年度报告 第一节 重要提示、目录和释义 本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的 真实、准确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承担个别和 连带的法律责任。 公司负责人李刚、主管会计工作负责人邓强及会计机构负责人(会计主管人 员)邓强声明:保证年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 公司不存在对生产经营、财务状况和持续盈利能力有严重不利影响的重大 风险因素。 公司经本次董事会审议通过的利润分配预案为:以 420000000 为基数,向 全体股东每 10 股转增 10 股, 不派发现金红利,不送红股。 2 | 第一节 | 重要提示、目录和释义 2 | | --- | --- | | 第二节 | 公司简介和主要财务指标 5 | | 第三节 | 公司业务概要 11 | | 第四节 | 管理 ...
皓宸医疗(002622) - 2015 Q3 - 季度财报
2015-10-29 16:00
2015 年 10 月 1 吉林永大集团股份有限公司 2015 年第三季度报告正文 吉林永大集团股份有限公司 Jilin Yongda Group CO., LTD. 2015 年第三季度报告正文 2015-095 吉林永大集团股份有限公司 2015 年第三季度报告正文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整,不存在虚 假记载、误导性陈述或者重大遗漏,并承担个别和连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人李刚、主管会计工作负责人邓强及会计机构负责人(会计主管人员)邓强声明:保证季度报 告中财务报表的真实、准确、完整。 2 吉林永大集团股份有限公司 2015 年第三季度报告正文 第二节 主要财务数据及股东变化 一、主要会计数据和财务指标 公司是否因会计政策变更及会计差错更正等追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增减 | | --- | --- | --- | --- | --- | | 总资产(元) | 1,457,273,375.97 | 1,40 ...
皓宸医疗(002622) - 2015 Q2 - 季度财报
2015-08-25 16:00
吉林永大集团股份有限公司 2015 年半年度报告全文 吉林永大集团股份有限公司 Jilin Yongda Group CO., LTD. 2015 半年度报告 2015-069 2015 年 08 月 1 吉林永大集团股份有限公司 2015 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的 真实、准确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承担个别和 连带的法律责任。 所有董事均已出席了审议本报告的董事会会议。 公司计划不派发现金红利,不送红股,不以公积金转增股本。 公司负责人李刚、主管会计工作负责人邓强及会计机构负责人(会计主管人 员)邓强声明:保证本半年度报告中财务报告的真实、准确、完整。 半年度报告中所涉及未来的经营计划和经营目标,并不代表公司的盈利预 测,也不构成公司对投资者的实质承诺,能否实现取决于市场状况变化等多种 因素,存在不确定性,请投资者注意投资风险。 2 | 第一节 | 重要提示、目录和释义 | 2 | | --- | --- | --- | | 第二节 | 公司简介 | 5 | | 第三节 | 会计数据和财务指标摘要 ...
皓宸医疗(002622) - 2015 Q1 - 季度财报
2015-04-08 16:00
吉林永大集团股份有限公司 2015 年第一季度报告正文 证券代码:002622 证券简称:永大集团 公告编号:2015-025 吉林永大集团股份有限公司 Jilin Yongda Group CO., LTD. 2015 年第一季度报告正文 2015-025 股票简称:永大集团 股票代码:002622 二〇一五年四月 1 吉林永大集团股份有限公司 2015 年第一季度报告正文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人吕永祥、主管会计工作负责人吕兰及会计机构负责人(会计主管 人员)邓强声明:保证季度报告中财务报表的真实、准确、完整。 2 吉林永大集团股份有限公司 2015 年第一季度报告正文 第二节 主要财务数据及股东变化 一、主要会计数据和财务指标 公司是否因会计政策变更及会计差错更正等追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增 | | --- | --- | - ...
皓宸医疗(002622) - 2014 Q4 - 年度财报
2015-02-03 16:00
Financial Performance - The company's operating revenue for 2014 was CNY 161,042,613.90, a decrease of 12.80% compared to CNY 184,680,609.77 in 2013[23] - The net profit attributable to shareholders for 2014 was CNY 47,253,534.67, an increase of 22.19% from CNY 38,671,545.51 in 2013[23] - The net profit after deducting non-recurring gains and losses was CNY 47,042,271.54, up 29.20% from CNY 36,410,499.09 in 2013[23] - The basic earnings per share for 2014 was CNY 0.32, representing a 23.08% increase from CNY 0.26 in 2013[23] - The total assets at the end of 2014 were CNY 1,405,211,236.57, reflecting a growth of 13.14% from CNY 1,242,029,644.44 at the end of 2013[23] - The net assets attributable to shareholders increased to CNY 1,219,608,514.66, a rise of 3.69% from CNY 1,176,254,979.99 in 2013[23] - The net cash flow from operating activities was CNY 59,724,239.19, down 13.85% from CNY 69,323,576.06 in 2013[23] - The weighted average return on equity for 2014 was 3.94%, an increase from 3.34% in 2013[23] Investment and Acquisitions - The company has successfully acquired a 9.28% stake in Fushun Bank, which is expected to become a new source of profit and enhance the company's overall strength[36] - The company established a wholly-owned subsidiary, Beijing Yongda Technology Co., Ltd., to serve as its marketing headquarters and R&D center, aiming to expand its marketing network from Beijing to nationwide and globally[37] - The company is actively seeking quality projects through capital operations, leveraging its financial and resource advantages[36] - The company has confirmed that there are no changes in the feasibility of the fundraising projects[92] Research and Development - The company is gradually increasing R&D investment to support new product development, with several products currently in testing phases[38] - In 2014, the company's total R&D expenditure was 8,954,922.39 yuan, a decrease of 37.95% compared to 14,430,688.35 yuan in 2013, primarily due to a reduction in R&D projects[55] - The R&D expenditure accounted for 5.56% of operating revenue in 2014, down from 7.81% in 2013, indicating a strategic shift in resource allocation[55] - The company obtained a total of 23 patents by the end of the reporting period, including 3 invention patents, 16 utility model patents, and 4 design patents[56] Marketing and Sales - The marketing network construction project was preliminarily completed by June 30, 2014, and is expected to synergize with other fundraising projects for significant growth in the company's main business[37] - The marketing strategy includes a dual approach with sales teams and agents to enhance market penetration as brand awareness grows[39] - The company has diversified its customer base, expanding into new industries such as power, railways, and real estate[68] Cost Management - The company reduced operating costs to ¥88,023,745.49, down 11.24% from the previous year[41] - The company's sales expenses for 2014 were 19,871,935.69 yuan, a decrease of 18.91% from the previous year, attributed to improved sales team management and reduced order volume[53] - Management expenses decreased by 16.90% to 35,820,993.88 yuan in 2014, reflecting effective internal control and cost management[53] - The raw material cost for the switch product category was 35,174,382.91 yuan in 2014, accounting for 81.83% of the total operating cost, down from 84.39% in 2013[50] Corporate Governance and Compliance - The company has not reported any discrepancies between domestic and international accounting standards regarding net profit and net assets[26][28] - The company has not faced any administrative penalties during the reporting period[120] - The company has maintained a consistent profit distribution policy, ensuring cash dividends are not less than 10% of the distributable profits for the year[110] - The company has not reported any significant changes in accounting policies related to derivative investments compared to the previous reporting period[82] Social Responsibility and Sustainability - The company has actively engaged in social responsibility initiatives, focusing on product safety, environmental protection, and community support[119] - The company has implemented measures for energy conservation and emission reduction, including the introduction of advanced technologies and the gradual elimination of high-energy-consuming equipment[119] - The company has maintained a strong focus on safety management, including the installation of fire and explosion prevention facilities and regular emergency drills[119] Shareholder Information - The company reported a total share count of 150,000,000 shares, with 71.81% being restricted shares prior to the change[180] - The top five shareholders collectively hold 71.10% of the company's shares, indicating a high level of ownership concentration[190] - The largest shareholder, Lv Yongxiang, is also the actual controller of the company, with family members holding significant stakes[190] - The company has not disclosed any recent changes in its shareholding structure due to stock issuance or other corporate actions[186]
皓宸医疗(002622) - 2014 Q3 - 季度财报
2014-10-29 16:00
2014 年 10 月 吉林永大集团股份有限公司 2014 年第三季度报告正文 证券代码:002622 证券简称:永大集团 公告编号:2014-043 吉林永大集团股份有限公司 Jilin Yongda Group CO., LTD. 2014 年第三季度报告正文 2014-043 1 吉林永大集团股份有限公司 2014 年第三季度报告正文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整,不存在虚 假记载、误导性陈述或者重大遗漏,并承担个别和连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人吕永祥、主管会计工作负责人吕兰及会计机构负责人(会计主管人员)邓强声明:保证季度 报告中财务报表的真实、准确、完整。 2 吉林永大集团股份有限公司 2014 年第三季度报告正文 第二节 主要财务数据及股东变化 一、主要会计数据和财务指标 公司是否因会计政策变更及会计差错更正等追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增减 | | --- | --- | --- | --- | --- ...
皓宸医疗(002622) - 2014 Q2 - 季度财报
2014-08-25 16:00
Financial Performance - The company's operating revenue for the first half of 2014 was ¥58,612,009.24, a decrease of 25.17% compared to ¥78,329,488.86 in the same period last year[18]. - The net profit attributable to shareholders was ¥14,675,916.56, down 26.25% from ¥19,899,054.52 year-on-year[18]. - The net profit after deducting non-recurring gains and losses was ¥14,390,151.29, a decline of 27.45% compared to ¥19,835,026.06 in the previous year[18]. - Basic and diluted earnings per share were both ¥0.100, down 23.08% from ¥0.130 in the previous year[18]. - The weighted average return on equity decreased to 1.24% from 1.73% year-on-year, a drop of 0.49%[18]. - The total operating profit for the first half of 2014 was CNY 16,010,986.21, a decrease of 27.8% compared to CNY 22,169,572.98 in the same period of 2013[141]. - The net profit attributable to the parent company was CNY 14,675,916.56, down 26.2% from CNY 19,899,054.52 year-on-year[141]. Cash Flow - The net cash flow from operating activities increased by 13.63% to ¥16,925,376.17 from ¥14,895,560.53 in the same period last year[18]. - The company reported a significant decrease of 86.90% in net cash flow from investing activities, down to CNY 20,230,368.14 from CNY 154,416,885.02[35]. - The net cash flow from operating activities was CNY 62,623,343.69, a significant improvement compared to the previous period's negative cash flow of CNY -44,973,004.69[149]. - Cash inflow from operating activities reached CNY 113,944,470.59, up from CNY 61,343,694.42 in the prior period, indicating a growth of approximately 85.9%[149]. - The net cash flow from investing activities was CNY -25,972.81, a decline from CNY 39,134,013.16 in the previous period[149]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,251,667,991.19, an increase of 0.78% from ¥1,242,029,644.44 at the end of the previous year[18]. - The total liabilities stand at ¥64,637,094.64, slightly down from ¥65,774,664.45, indicating a stable debt position[135]. - The total equity attributable to the parent company increased to CNY 1,187,030,896.55 from CNY 1,176,254,979.99, reflecting a growth of approximately 0.9%[153]. Operational Strategy - The company aims to strengthen internal control and cost management while focusing on core business and market strategies[32]. - The company plans to adopt a comprehensive industrial extension strategy and a combined marketing approach to enhance profitability and seek development opportunities[66]. - The company is currently constructing fundraising investment projects, with progress reported as normal[33]. Shareholder Information - The total number of shares is 150,000,000, with 71.81% being restricted shares and 28.19% being unrestricted shares[110]. - The largest shareholder, Lv Yongxiang, holds 33.66% (50,482,600 shares) of the company[114]. - The total number of common stock shareholders at the end of the reporting period is 10,937[114]. Regulatory Compliance - The half-year financial report was not audited[105]. - The company has maintained compliance with all regulatory requirements regarding the use of raised funds[60]. - The company has not reported any significant changes in its asset and liability structure during the reporting period[112]. Investment and Projects - The total amount of raised funds is 727,815,113.46 CNY after deducting issuance costs of 32,184,886.54 CNY from the gross amount of 760,000,000.00 CNY[53]. - The company has utilized CNY 6,000 million of raised funds to establish a wholly-owned subsidiary in Beijing for marketing and R&D purposes[57]. - The company has not engaged in derivative investments or entrusted loans during the reporting period[50][51]. Market Conditions - The decline in net profit is attributed to a downturn in both international and domestic economies, leading to decreased customer demand and project delays[66]. - The company warns that future operational plans and targets are subject to market conditions and uncertainties, and do not constitute a commitment to investors[6].
皓宸医疗(002622) - 2014 Q1 - 季度财报
2014-04-25 16:00
Financial Performance - Revenue for Q1 2014 was CNY 19,913,111.35, a decrease of 29.6% compared to CNY 28,285,232.04 in the same period last year[10] - Net profit attributable to shareholders was CNY 4,086,092.52, down 14.92% from CNY 4,802,767.76 year-on-year[10] - Net cash flow from operating activities was negative CNY 8,140,315.37, a decline of 198.96% compared to positive CNY 8,226,278.46 in the previous year[10] - The net profit attributable to shareholders for the first half of 2014 is expected to decline by 48% to 21%, ranging from 10.348 million to 15.721 million yuan[22] - The net profit for the first half of 2013 was 19.90 million yuan, indicating a significant decrease in performance year-over-year[22] Assets and Equity - Total assets at the end of the reporting period were CNY 1,244,928,039.56, an increase of 0.23% from CNY 1,242,029,644.44 at the end of the previous year[10] - Net assets attributable to shareholders increased by 0.35% to CNY 1,180,341,072.51 from CNY 1,176,254,979.99 at the end of the previous year[10] Shareholder Information - The total number of shareholders at the end of the reporting period was 9,772[13] - The top shareholder, Lv Yongxiang, holds 33.66% of the shares, totaling 50,482,600 shares[13] - The company has made commitments to shareholders regarding the transfer and management of shares, ensuring stability in shareholding[21] Operational Insights - The company reported non-operating income of CNY 254,532.80 after tax adjustments[11] - The company is actively exploring new industry clients to mitigate the impact of deteriorating conditions in traditional industry clients[22] Investment Status - There are no securities investments reported during the period, with no shares held or changes in investment status[24] Earnings Per Share - Basic and diluted earnings per share remained unchanged at CNY 0.03[10] Return on Equity - The weighted average return on equity decreased to 0.35% from 0.42% year-on-year[10]
皓宸医疗(002622) - 2013 Q4 - 年度财报
2014-03-27 16:00
Financial Performance - The company's operating revenue for 2013 was CNY 184,680,609.77, a decrease of 24.52% compared to CNY 244,681,605.58 in 2012[25]. - The net profit attributable to shareholders for 2013 was CNY 38,671,545.51, down 28.95% from CNY 54,429,110.95 in the previous year[25]. - The net profit after deducting non-recurring gains and losses was CNY 36,410,499.09, a decline of 29.35% compared to CNY 51,538,812.01 in 2012[25]. - The basic earnings per share for 2013 was CNY 0.26, a decrease of 27.78% from CNY 0.36 in 2012[25]. - The total assets at the end of 2013 were CNY 1,242,029,644.44, reflecting a growth of 5.55% from CNY 1,176,674,529.89 at the end of 2012[25]. - The net assets attributable to shareholders increased by 3.4% to CNY 1,176,254,979.99 from CNY 1,137,583,434.48 in 2012[25]. - The weighted average return on equity for 2013 was 3.34%, down from 4.8% in 2012[25]. - The total profit for the period was 47.58 million yuan, with a net profit of 38.67 million yuan[43]. - The company achieved operating revenue of 184.68 million yuan, a year-on-year decrease of 24.52%[44]. - The company's operating costs amounted to CNY 98,149,076.50, reflecting a decrease of 24.63% year-on-year[69]. - The gross profit margin for the electrical switch industry was 58%, down by 2.65% from the previous year[69]. Cash Flow and Investments - The net cash flow from operating activities increased by 71.6% to CNY 69,323,576.06 from CNY 40,397,984.93 in 2012[25]. - The company reported a net increase in cash and cash equivalents of CNY 174,935,722.01, a significant turnaround from a decrease of CNY 97,455,600.02 in the previous year[64][67]. - Operating cash inflow decreased by 18.29% to CNY 259,515,780.63, primarily due to a reduction in contract amounts[64][65]. - The company has committed a total investment of CNY 30,059.18 million for various projects, with a cumulative investment of CNY 9,247.96 million, representing 30.73% of the planned investment progress[104]. - The company has utilized CNY 2,020 million of the raised funds to repay bank loans, achieving 100% of the intended use[104]. Research and Development - Research and development expenses increased by 2.94% to 14.43 million yuan, reflecting the company's commitment to innovation[44]. - The company is increasing its R&D investment and has several new products in the testing phase, aiming to improve product performance and innovation[40]. - The company is exploring new product development, particularly in the field of permanent magnet switches[138]. Market Strategy and Operations - The company is establishing a wholly-owned subsidiary in Beijing to serve as its marketing headquarters and R&D center, aiming to expand its marketing network nationwide and globally[41]. - The company has initiated a dual marketing strategy by maintaining its sales elite team while introducing an agent mechanism to improve market promotion effectiveness[42]. - The company has diversified its customer base, expanding into new industries such as power, railways, and real estate, which is expected to increase market share[79]. - The company plans to enhance its overall strength and broaden profit sources in 2014[114]. - The marketing strategy will involve tracking key customers and developing more industry-leading clients[116]. Dividend Policy - The company plans to distribute a cash dividend of CNY 0.26 per 10 shares to all shareholders[7]. - The cash dividend for 2013 represents 10.08% of the net profit attributable to shareholders, which is 38,671,545.51 yuan[130]. - The company has a policy to distribute at least 10% of the annual distributable profit in cash dividends, and the cumulative cash distribution over three consecutive years should not be less than 30% of the average annual distributable profit[132]. - The remaining undistributed profit for 2013 is 313,294,643.92 yuan, which will be carried forward to the next year[132]. Risk Management and Compliance - There are no significant risk factors adversely affecting the company's production, financial status, or ongoing profitability[14]. - The company has implemented internal audits to enhance management and risk control, improving operational efficiency and execution across various departments[41]. - The company has actively engaged in social responsibility initiatives, focusing on product safety, environmental protection, and community support[133]. - The company has not been subject to any administrative penalties during the reporting period[136]. - The company operates in an industry that is not classified as a heavily polluting industry by national environmental protection standards[134]. Shareholder Information - The total number of shares is 150,000,000, with 71.81% being restricted shares and 28.19% being unrestricted shares[190]. - The largest shareholder, Lv Yongxiang, holds 33.66% of the shares, amounting to 50,482,600 shares[199]. - The company has 12,243 shareholders at the end of the reporting period, an increase from 10,278 shareholders five trading days prior[199]. - The shareholding structure indicates that the top ten shareholders collectively hold 71.35% of the company's shares, with significant family ties among them[199].